Galectin Therapeutics Inc (GALT) Unusual Options Activity Today

Checking GALT unusual options activity helps you spot when traders are making outsized bets on Galectin Therapeutics Inc before the broader market catches on. Galectin Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor GALT unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching GALT unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking GALT unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and GALT unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis.

The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Catalysts rarely arrive without a footprint, and GALT unusual options activity is often where that footprint shows up first. Our scanner tracks Galectin Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at GALT unusual options volume on the call side or chasing put sweeps, Galectin Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.